TY - JOUR
T1 - Integrating smoking cessation support during lung cancer diagnostic workup
T2 - a pragmatic, multicenter, cluster-randomised controlled trial
AU - Farver-Vestergaard, Ingeborg
AU - Wellnitz, Kaare Bro
AU - Hilberg, Ole
AU - Borg, Morten
AU - Christensen, Helle Marie
AU - Bodtger, Uffe
AU - Lyhne, Niels
AU - Lavesen, Marie
AU - Ralli, Maria
AU - Løkke, Anders
N1 - Publisher Copyright:
2025 Farver-Vestergaard, Wellnitz, Hilberg, Borg, Christensen, Bodtger, Lyhne, Lavesen, Ralli and Løkke.
PY - 2025
Y1 - 2025
N2 - Background: Smoking cessation at or around the time of lung cancer diagnosis is associated with improved treatment outcomes, enhanced quality of life and increased survival. However, many patients continue smoking post-diagnosis. Aim: This study evaluated the effectiveness of a national initiative in Denmark that integrated smoking cessation support into the diagnostic workup for lung cancer within a pragmatic, multicenter, cluster-randomised controlled trial. Methods: Nine Danish hospitals were cluster-randomised to either the intervention group (integrated cessation support) or the control group (usual care). The intervention was implemented in five hospitals. Eighty-six patients (intervention = 39; control = 47) who were active smokers at referral completed questionnaires assessing smoking cessation initiation, motivation, quality of life and psychosocial consequences of diagnostic workup at baseline and 6-weeks follow-up. Logistic and multiple regression analyses were conducted. Additionally, 140 healthcare professionals completed a survey on cessation support practices pre-intervention, and 54 completed it post-intervention. Descriptive analyses were used to assess changes in clinical practice. Results: There were no statistically significant differences in smoking cessation initiation between the intervention and control groups (OR = 0.81 [0.41, 1.58], p = 0.53; adjusted OR = 0.79 [0.35, 1.79], p = 0.57). Among healthcare professionals in the intervention group, a larger proportion reported they “almost always” provided cessation after the implementation (35.1%) than before (18.3%). But the proportion who responded that they “almost never” provide support was also considerably larger after the implementation (13.5%) than before (3.2%). In the control group, proportions tended to shift more generally towards providing more support over time, and a considerably larger proportion reported to refer patients to external smoking cessation support at the follow-up measurement. Conclusion: The study was inconclusive, showing no significant effect of smoking cessation support during lung cancer diagnostic workup on patients' cessation initiation, possibly influenced by selection bias and varying intervention fidelity at study sites.
AB - Background: Smoking cessation at or around the time of lung cancer diagnosis is associated with improved treatment outcomes, enhanced quality of life and increased survival. However, many patients continue smoking post-diagnosis. Aim: This study evaluated the effectiveness of a national initiative in Denmark that integrated smoking cessation support into the diagnostic workup for lung cancer within a pragmatic, multicenter, cluster-randomised controlled trial. Methods: Nine Danish hospitals were cluster-randomised to either the intervention group (integrated cessation support) or the control group (usual care). The intervention was implemented in five hospitals. Eighty-six patients (intervention = 39; control = 47) who were active smokers at referral completed questionnaires assessing smoking cessation initiation, motivation, quality of life and psychosocial consequences of diagnostic workup at baseline and 6-weeks follow-up. Logistic and multiple regression analyses were conducted. Additionally, 140 healthcare professionals completed a survey on cessation support practices pre-intervention, and 54 completed it post-intervention. Descriptive analyses were used to assess changes in clinical practice. Results: There were no statistically significant differences in smoking cessation initiation between the intervention and control groups (OR = 0.81 [0.41, 1.58], p = 0.53; adjusted OR = 0.79 [0.35, 1.79], p = 0.57). Among healthcare professionals in the intervention group, a larger proportion reported they “almost always” provided cessation after the implementation (35.1%) than before (18.3%). But the proportion who responded that they “almost never” provide support was also considerably larger after the implementation (13.5%) than before (3.2%). In the control group, proportions tended to shift more generally towards providing more support over time, and a considerably larger proportion reported to refer patients to external smoking cessation support at the follow-up measurement. Conclusion: The study was inconclusive, showing no significant effect of smoking cessation support during lung cancer diagnostic workup on patients' cessation initiation, possibly influenced by selection bias and varying intervention fidelity at study sites.
KW - addiction
KW - cancer
KW - implementation
KW - nicotine
KW - respiratory disease
UR - http://www.scopus.com/inward/record.url?scp=105025455029&partnerID=8YFLogxK
U2 - 10.3389/frhs.2025.1696454
DO - 10.3389/frhs.2025.1696454
M3 - Journal article
C2 - 41445708
AN - SCOPUS:105025455029
SN - 2813-0146
VL - 5
JO - Frontiers in Health Services
JF - Frontiers in Health Services
M1 - 1696454
ER -